Breaking News Instant updates and real-time market news.

TEVA

Teva

$19.12

0.31 (1.65%)

08:40
02/13/19
02/13
08:40
02/13/19
08:40

Teva CEO says 'no plans' to do significant acquisitions 'of any kind'

  • 13

    Feb

TEVA Teva
$19.12

0.31 (1.65%)

01/23/19
01/23/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Walmart (WMT) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Simeon Gutman citing his belief that Walmart U.S. can now generate sales growth without sacrificing margins, unlike most retailers. 2. Teva (TEVA) upgraded to Buy from Neutral at UBS and to Neutral from Underweight at Piper Jaffray. 3. D.R. Horton (DHI) upgraded to Buy from Neutral at Mizuho with analyst Haendel St. Juste saying stock selectivity is becoming more important in these latter stages of the housing cycle and larger platforms with price point diversification and strong balance sheets will be rewarded. 4. Logitech (LOGI) upgraded to Overweight from Neutral at JPMorgan and to Hold from Sell at Maxim. 5. Lamb Weston (LW) upgraded to Buy from Hold at Stifel with analyst Christopher Growe saying he is confident in the "growth profile of the business continuing amidst the very strong operating conditions in the category." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/25/19
PIPR
01/25/19
NO CHANGE
PIPR
Report that CVS excluded Amgen's Aimovig 'greatly exaggerated,' says Piper
Piper Jaffray analyst Christopher Raymond kept an Overweight rating and $220 price target on Amgen (AMGN) following a Reuters report from earlier on Friday which stated that CVS (CVS) has excluded Amgen's Aimovig from its formulary. The analyst called the report "Friday afternoon clickbait" and noted that while CVS currently provides preferred status to Teva's (TEVA) Ajovy and Eli Lilly's (LLY) Emgality, this was made public in late 2018. In a check with management, Raymond found out the decision only encompasses about one-third of CVS network, that CVS is actively working to improve this access, and that 70% of commercial migraine patients have contracted access to Aimovig. Raymond concluded that this was "not something to worry about" in his view, and did not change his Q4, FY19, or FY20 estimates on Aimovig. In Friday trading, shares of Amgen were down just over 1% to $198.77.
01/30/19
WELS
01/30/19
NO CHANGE
WELS
Wells says Novartis report read-through 'neutral to negative' for Mylan, Teva
After Novartis' (NVS) Sandoz generics unit reported Q4 sales were down 2% in constant currency, due to a 7% decline in price and 5% increase in volume, Wells Fargo analyst David Maris noted that the majority of the price erosion came from the U.S. While the 2% decline was a sequential improvement from down 4% in Q3, Novartis was up against an easy comparison in the year ago period, Maris added. His view is that the U.S. generic market has not materially changed or improved at this point and he contends the report has a "neutral to negative read-through" relative to investors' expectations for Mylan (MYL) and Teva (TEVA).
02/01/19
WELS
02/01/19
NO CHANGE
Target $46
WELS
Market Perform
Perrigo's ProAir opportunity 'may be vaporizing,' says Wells Fargo
Wells Fargo analyst David Maris noted that GlaxoSmithKline (GSK) launched an authorized generic of Ventolin on January 15 and he has now learned that Teva (TEVA) may have "surprisingly launched" an authorized generic of ProAir in response to the generic Ventolin pressure prior to Perrigo's (PRGO) approval. Pricing pressure from generic Ventolin, in addition to the launch of an authorized generic well ahead of Perrigo's own generic ProAir launch, seem to have significantly diminished Perrigo's generic ProAir opportunity, Maris tells investors. He keeps a Market Perform rating and $46 price target on Perrigo shares.

TODAY'S FREE FLY STORIES

KPTI

Karyopharm

$9.04

0.08 (0.89%)

12:32
02/22/19
02/22
12:32
02/22/19
12:32
Hot Stocks
Breaking Hot Stocks news story on Karyopharm »

Karyopharm trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 28

    Feb

  • 06

    Apr

BIDU

Baidu

$166.90

-4.82 (-2.81%)

12:30
02/22/19
02/22
12:30
02/22/19
12:30
Options
10.1K Baidu Mar 170 - Sep 165 put spreads trade $7.20 after earnings »

10.1K Baidu Mar 170 - Sep…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

UBS

UBS

$12.38

0.055 (0.45%)

12:30
02/22/19
02/22
12:30
02/22/19
12:30
Periodicals
UBS ignored warnings in French tax case for years, Reuters says »

According to a written…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:30
02/22/19
02/22
12:30
02/22/19
12:30
General news
FX Action: USD-JPY »

FX Action: USD-JPY traded…

12:25
02/22/19
02/22
12:25
02/22/19
12:25
General news
Fed VC Clarida said the Fed should be "open minded" »

Fed VC Clarida said the…

GM

General Motors

$39.67

0.04 (0.10%)

12:23
02/22/19
02/22
12:23
02/22/19
12:23
Hot Stocks
GM says over 1,500 employees volunteered to transfer to other U.S. locations »

General Motors said that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

GM

General Motors

$39.66

0.03 (0.08%)

12:21
02/22/19
02/22
12:21
02/22/19
12:21
Hot Stocks
GM extends production at Detroit/Hamtramck into January 2020 »

GM said it has notified…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

NWSA

News Corp.

$13.04

0.25 (1.95%)

12:20
02/22/19
02/22
12:20
02/22/19
12:20
Options
Notable print in News Corp puts »

Notable print in News…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
02/22/19
02/22
12:17
02/22/19
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
02/22/19
02/22
12:16
02/22/19
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FOX

21st Century Fox

$50.60

0.14 (0.28%)

, FOXA

21st Century Fox

$50.89

0.15 (0.30%)

12:14
02/22/19
02/22
12:14
02/22/19
12:14
Periodicals
Fox removes Jussie Smollett from last two episodes of 'Empire' season, WSJ says »

Producer's of Fox…

FOX

21st Century Fox

$50.60

0.14 (0.28%)

FOXA

21st Century Fox

$50.89

0.15 (0.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Mar

12:13
02/22/19
02/22
12:13
02/22/19
12:13
On The Fly
Fly Intel: Wall Street's top stories at midday »

Stocks opened with modest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DBVT

DBV Technologies

$7.70

-0.26 (-3.27%)

12:05
02/22/19
02/22
12:05
02/22/19
12:05
Periodicals
JAMA editorial says DBV trial results 'not easy to interpret' »

In an editorial published…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GME

GameStop

$11.15

0.12 (1.09%)

12:05
02/22/19
02/22
12:05
02/22/19
12:05
Options
GameStop call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LTN

Union Acquisition Corp

$5.89

-1.44 (-19.65%)

12:00
02/22/19
02/22
12:00
02/22/19
12:00
Hot Stocks
Union Acquisition Corp falls -17.3% »

Union Acquisition Corp is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

TDS

Telephone and Data

$32.14

-4.55 (-12.40%)

12:00
02/22/19
02/22
12:00
02/22/19
12:00
Hot Stocks
Telephone and Data falls -12.5% »

Telephone and Data is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 22

    Feb

DPLO

Diplomat Pharmacy

$7.65

-5.81 (-43.16%)

12:00
02/22/19
02/22
12:00
02/22/19
12:00
Hot Stocks
Diplomat Pharmacy falls -42.9% »

Diplomat Pharmacy is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 11

    Mar

  • 12

    Mar

PBI

Pitney Bowes

$8.25

1.225 (17.45%)

12:00
02/22/19
02/22
12:00
02/22/19
12:00
Hot Stocks
Pitney Bowes rises 17.4% »

Pitney Bowes is up 17.4%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

  • 28

    Mar

SWM

Schweitzer-Mauduit

$41.20

6.51 (18.77%)

12:00
02/22/19
02/22
12:00
02/22/19
12:00
Hot Stocks
Schweitzer-Mauduit rises 19.0% »

Schweitzer-Mauduit is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 22

    Feb

  • 28

    Mar

W

Wayfair

$153.23

36.09 (30.81%)

12:00
02/22/19
02/22
12:00
02/22/19
12:00
Hot Stocks
Wayfair rises 30.9% »

Wayfair is up 30.9%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 22

    Feb

  • 03

    Mar

CAG

Conagra Brands

$23.13

-0.95 (-3.95%)

11:55
02/22/19
02/22
11:55
02/22/19
11:55
Options
ConAgra put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:55
02/22/19
02/22
11:55
02/22/19
11:55
General news
FX Action: USD-CAD »

FX Action: USD-CAD has…

11:55
02/22/19
02/22
11:55
02/22/19
11:55
Conference/Events
William Blair medical tech analyst to hold a luncheon »

Medical Technology &…

TKR

Timken

$43.82

0.41 (0.94%)

11:51
02/22/19
02/22
11:51
02/22/19
11:51
Conference/Events
Timken management to meet with KeyBanc »

Meetings to be held on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

KPTI

Karyopharm

$8.97

0.01 (0.11%)

11:50
02/22/19
02/22
11:50
02/22/19
11:50
Recommendations
Karyopharm analyst commentary  »

H.C. Wainwright sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 28

    Feb

  • 06

    Apr

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.